BioCentury
ARTICLE | Financial News

Frontier raises RMB300M in series C

January 6, 2017 11:51 PM UTC

Frontier Biotechnologies Co. Ltd. (Nanjing, China) said it raised RMB300 million ($43.2 million) in a series C round led by Huaxin Century. Shenzhen Capital, Efung Capital and undisclosed other investors also participated. ...

BCIQ Company Profiles

Frontier Biotechnologies Inc.